Cart
sales@molnova.com
Calpain Inhibitor Peptide
CAS No. 128578-18-7
Calpain Inhibitor Peptide( ——— )
Catalog No. M41333 CAS No. 128578-18-7
Calpastatin subdomain B is a biological active peptide. (inhibit calpain activity)
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCalpain Inhibitor Peptide
-
NoteResearch use only, not for human use.
-
Brief DescriptionCalpastatin subdomain B is a biological active peptide. (inhibit calpain activity)
-
DescriptionCalpastatin subdomain B is a biological active peptide. (inhibit calpain activity)
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number128578-18-7
-
Formula Weight3136.57
-
Molecular FormulaC140H227N35O44S
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
RS5517
RS5517 is a novel PDZ1 structural domain ligand for the study of colorectal cancer.
-
Acetyl hexapeptide 3...
Acetyl hexapeptide 38, breast enhancement peptide, is a kind of acetylated hexapeptide, can significantly stimulate the use of the site of fat synthesis, increase the volume of the chest or cheek, shape the perfect body
-
Disitamab vedotin
Disitamab vedotin (RC-48) is a newly developed antibody-active molecule conjugate (ADC) targeting human epidermal growth factor receptor 2 (HER2), consisting of hertuzumab coupled to monomethyl auristatin E (MMAE) via a cleavable linker.
